About
Biobase, Inc. (San Diego, founded 2025) builds an agentic operating system and infrastructure layer for clinical data, normalizing and indexing records across health systems without moving raw data, and using AI agents to automate cohort discovery, analytics and data-access workflows for pharma, biotech and AI developers.
Capital graph
Founders / team· 4
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Biobase
Biobase, Inc. (San Diego, founded 2025) builds an agentic operating system and infrastructure layer for clinical data, normalizing and indexing records across health systems without moving raw data, and using AI agents to automate cohort discovery, analytics and data-access workflows for pharma, biotech and AI developers.
—
United States
BusinessLatest roundTotal raisedDate- Datavant
Healthcare data collaboration platform: secure linkage, de-identification and exchange of medical records across institutions
Strategic · $83M · 2026-09
$83M - Harmonic Security
AI usage governance and DLP: real-time detection and blocking across browsers, desktop AI apps and AI agent workflows (Harmonic Explore/Guide/Command), integrated with Anthropic Claude Compliance API, Cisco and others.
Series B · $76M · 2026-10
$76M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Agora Labs
On-premises clinical data standardization, anonymization and federated learning infrastructure for hospitals, clinical research centers, life sciences companies and AI researchers, enabling compliant use of real-world data for research and AI model training
2026-10
— - TietAI
AI-native healthcare data integration and interoperability platform (Hydra) for hospitals and healthcare providers
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
25 Life Sciences deals in the last 24 months · 23 in US West Coast
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.